These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7333090)

  • 1. Human platelet monoamine oxidase activity and in vivo manipulation of plasma glucose concentration.
    Jackman HL; Meltzer HY
    Commun Psychopharmacol; 1980; 4(5):335-8. PubMed ID: 7333090
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of oral glucose on platelet monoamine oxidase.
    Karson CN; Bridge TP; Phelps BH; Wise CD; Potkin SG; Apostoles PS; Wyatt RJ
    Biol Psychiatry; 1982 Sep; 17(9):1011-5. PubMed ID: 7138991
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet monoamine oxidase activity in schizophrenia.
    Psychopharmacol Bull; 1981 Jul; 17(3):26-31. PubMed ID: 6117103
    [No Abstract]   [Full Text] [Related]  

  • 4. [A long-term observation of the platelet monoamine oxidase activity in schizophrenic patients (author's transl)].
    Shohmori T; Kaneyuki T; Doi T; Mitani K; Kohsaka M
    Seishin Shinkeigaku Zasshi; 1978 Mar; 80(3):121-4. PubMed ID: 662975
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet monoamine oxidase activity in anergic schizophrenics.
    Shaskan EG; Becker RE
    Psychopharmacol Bull; 1975 Jul; 11(3):39-40. PubMed ID: 1153659
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity.
    Baron M; Levitt M; Asnis L; Fein M
    Biol Psychiatry; 1983 May; 18(5):579-82. PubMed ID: 6860731
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet monoamine oxidase in schizophrenia with beta-phenylethylamine and benzylamine as substrates.
    Baron M; Perumal AS; Levitt M; Cannova G
    Biol Psychiatry; 1982 Apr; 17(4):479-83. PubMed ID: 7082713
    [No Abstract]   [Full Text] [Related]  

  • 8. On the relation between platelet monoamine oxidase activity and the growth hormone response in psychosis.
    Hitzemann R; Hirschowitz J; Zemlan F; Hitzemann B; Garver D
    Biol Psychiatry; 1983 Dec; 18(12):1503-7. PubMed ID: 6661478
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet monoamine oxidase and the growth hormone response to apomorphine in schizophrenia.
    Malas KL; van Kammen DP; deFraites EA; Brown GM; Gold PW
    Biol Psychiatry; 1983 Feb; 18(2):255-9. PubMed ID: 6830934
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary study on platelet monoamine oxidase in schizophrenic patients].
    Huang MS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Apr; 13(4):193-6. PubMed ID: 7261730
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet monoamine oxidase activity in patients with chronic schizophrenic illnesses untreated by neuroleptic drugs [proceedings].
    Bailey AR; Crow TJ; Johnstone EC; Owen F
    Br J Clin Pharmacol; 1975 Aug; 2(4):380P. PubMed ID: 1234010
    [No Abstract]   [Full Text] [Related]  

  • 12. Eye-blink rates and platelet monoamine oxidase activity in chronic schizophrenic patients.
    Freed WJ; Kleinman JE; Karson CN; Potkin SG; Murphy DL; Wyatt RJ
    Biol Psychiatry; 1980 Apr; 15(2):329-32. PubMed ID: 7417620
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients.
    Meltzer HY; Stahl SM
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):419-31. PubMed ID: 4594367
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet monoamine oxidase activity in chronic schizophrenia.
    Trivedi JK; Tandon SK; Viswanathan PN; Gupta AK; Sethi BB
    Indian J Med Res; 1987 Jul; 86():79-83. PubMed ID: 3692563
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet monoamineoxidase activity in chronic schizophrenics.
    Gerbaldo H; Rozados RV; Filinger EJ
    Medicina (B Aires); 1985; 45(1):22-4. PubMed ID: 3880103
    [No Abstract]   [Full Text] [Related]  

  • 16. Delusional misidentification and platelet monoamine oxidase.
    Barton JL; Chaparala S; Barton ES; Jackson IV; Davis LG
    Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of MAO concentration and activity in schizophrenic patients.
    Abell CW; Fritz RB; Landowski J; Bessman JD; Castellani S; Boeringa JA; Rose RM
    Prog Clin Biol Res; 1982; 79():209-21. PubMed ID: 7088965
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet monoamine oxidase and blood plasma benzylamine oxidase activity in cirrhotic patients.
    Cortesini C; Buffoni F; Ignesti G; Pirisino R; Sestini MC
    Boll Soc Ital Biol Sper; 1982 Aug; 58(15):982-6. PubMed ID: 7126373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.